273 related articles for article (PubMed ID: 33785492)
1. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
[TBL] [Abstract][Full Text] [Related]
2. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ; Guchelaar NAD; van den Heuvel TBM; Lurvink RJ; van Meerten E; Bax RJF; Creemers GM; van Hellemond IEG; Brandt-Kerkhof ARM; Madsen EVE; Nederend J; Koolen SLW; Nienhuijs SW; Kranenburg O; de Hingh IHJT; Verhoef C; Mathijssen RHJ; Burger JWA; ;
BMJ Open; 2024 Jan; 14(1):e077667. PubMed ID: 38238055
[TBL] [Abstract][Full Text] [Related]
4. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
Rovers KP; Wassenaar ECE; Lurvink RJ; Creemers GM; Burger JWA; Los M; Huysentruyt CJR; van Lijnschoten G; Nederend J; Lahaye MJ; Deenen MJ; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Ann Surg Oncol; 2021 Sep; 28(9):5311-5326. PubMed ID: 33544279
[TBL] [Abstract][Full Text] [Related]
5. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
[TBL] [Abstract][Full Text] [Related]
6. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Lurvink RJ; Tajzai R; Rovers KP; Wassenaar ECE; Moes DAR; Pluimakers G; Boerma D; Burger JWA; Nienhuijs SW; de Hingh IHJT; Deenen MJ
Ann Surg Oncol; 2021 Jan; 28(1):265-272. PubMed ID: 32572849
[TBL] [Abstract][Full Text] [Related]
7. Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
Rovers KP; Bakkers C; Nienhuijs SW; Burger JWA; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; van Meerten E; Tuynman JB; Kusters M; Versteeg KS; Aalbers AGJ; Kok NFM; Buffart TE; Wiezer MJ; Boerma D; Los M; de Reuver PR; Bremers AJA; Verheul HMW; Kruijff S; de Groot DJA; Witkamp AJ; van Grevenstein WMU; Koopman M; Nederend J; Lahaye MJ; Kranenburg O; Fijneman RJA; van 't Erve I; Snaebjornsson P; Hemmer PHJ; Dijkgraaf MGW; Punt CJA; Tanis PJ; de Hingh IHJT;
JAMA Surg; 2021 Aug; 156(8):710-720. PubMed ID: 34009291
[TBL] [Abstract][Full Text] [Related]
8. Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.
de Boer NL; Brandt-Kerkhof ARM; Madsen EVE; Diepeveen M; van Meerten E; van Eerden RAG; de Man FM; Bouamar R; Koolen SLW; de Hingh IHJT; Bakkers C; Rovers KP; Creemers GM; Deenen MJ; Kranenburg OW; Constantinides A; Mathijssen RHJ; Verhoef C; Burger JWA; ;
BMJ Open; 2019 Dec; 9(12):e034508. PubMed ID: 31818845
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study.
Taibi A; Sgarbura O; Hübner M; Bardet SM; Alyami M; Bakrin N; Durand Fontanier S; Eveno C; Gagniere J; Pache B; Pocard M; Quenet F; Teixeira Farinha H; Thibaudeau E; Dumont F; Glehen O
Ann Surg Oncol; 2022 Aug; 29(8):5243-5251. PubMed ID: 35318519
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).
Lurvink RJ; Rovers KP; Wassenaar ECE; Bakkers C; Burger JWA; Creemers GM; Los M; Mols F; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
Surg Endosc; 2022 Jun; 36(6):4486-4498. PubMed ID: 34757489
[TBL] [Abstract][Full Text] [Related]
11. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C; Antoniotti C; Rossini D; Lonardi S; Loupakis F; Pietrantonio F; Bordonaro R; Latiano TP; Tamburini E; Santini D; Passardi A; Marmorino F; Grande R; Aprile G; Zaniboni A; Murgioni S; Granetto C; Buonadonna A; Moretto R; Corallo S; Cordio S; Antonuzzo L; Tomasello G; Masi G; Ronzoni M; Di Donato S; Carlomagno C; Clavarezza M; Ritorto G; Mambrini A; Roselli M; Cupini S; Mammoliti S; Fenocchio E; Corgna E; Zagonel V; Fontanini G; Ugolini C; Boni L; Falcone A;
Lancet Oncol; 2020 Apr; 21(4):497-507. PubMed ID: 32164906
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal paclitaxel combined with FOLFOX/CAPOX plus bevacizumab for colorectal cancer with peritoneal carcinomatosis (the iPac-02 trial): study protocol of a single arm, multicenter, phase 2 study.
Murono K; Yokoyama Y; Nozawa H; Sasaki K; Emoto S; Matsuzaki H; Kashiwabara K; Ishigami H; Gohda Y; Yamaguchi H; Kitayama J; Ishihara S
Int J Colorectal Dis; 2023 Jun; 38(1):173. PubMed ID: 37340243
[TBL] [Abstract][Full Text] [Related]
13. Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
Satake H; Ando K; Oki E; Shimokawa M; Makiyama A; Saeki H; Tsuji A; Mori M
BMC Cancer; 2020 Nov; 20(1):1116. PubMed ID: 33203393
[TBL] [Abstract][Full Text] [Related]
14. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
[TBL] [Abstract][Full Text] [Related]
15. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
16. Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.
Tabchouri N; Buggisch J; Demtröder CR; Thiery J; Rezniczek G; Tempfer CB; Fischer B; Dogan C; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2021 Sep; 28(9):5275-5286. PubMed ID: 33471267
[TBL] [Abstract][Full Text] [Related]
17. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.
Lurvink RJ; Rovers KP; Nienhuijs SW; Creemers GJ; Burger JWA; de Hingh IHJ
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S242-S258. PubMed ID: 33968441
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
[TBL] [Abstract][Full Text] [Related]
19. Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
van de Vlasakker VCJ; Lurvink RJ; Wassenaar EC; Rauwerdink P; Bakkers C; Rovers KP; Bonhof CS; Burger JWA; Wiezer MJ; Boerma D; Nienhuijs SW; Mols F; de Hingh IHJT
Sci Rep; 2023 Nov; 13(1):20458. PubMed ID: 37993560
[TBL] [Abstract][Full Text] [Related]
20. Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases.
Taibi A; Teixeira Farinha H; Durand Fontanier S; Sayedalamin Z; Hübner M; Sgarbura O
Ann Surg Oncol; 2021 Jul; 28(7):3852-3860. PubMed ID: 33216263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]